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Fungicidal activity of peptides 
encoded by immunoglobulin genes
Luciano Polonelli1, Tecla Ciociola1, Martina Sperindè1, Laura Giovati1, Tiziana D’Adda1,  
Serena Galati2, Luiz R. Travassos  3, Walter Magliani1 & Stefania Conti  1
Evidence from previous works disclosed the antimicrobial, antiviral, anti-tumour and/or 
immunomodulatory activity exerted, through different mechanisms of action, by peptides expressed in 
the complementarity-determining regions or even in the constant region of antibodies, independently 
from their specificity and isotype. Presently, we report the selection, from available databases, of 
peptide sequences encoded by immunoglobulin genes for the evaluation of their potential biological 
activities. Synthetic peptides representing the translated products of J lambda and J heavy genes 
proved to act in vitro against pathogenic fungi, entering yeast cells and causing their death, and exerted 
a therapeutic effect in a Galleria mellonella model of infection by Candida albicans. No haemolytic, 
cytotoxic and genotoxic effects were observed on mammalian cells. These findings raise the hypothesis 
that antibodies could be the evolutionary result of the adaptive combination of gene products 
ancestrally devoted to innate antimicrobial immunity.
It is well known that the entire repertoire of human immunoglobulins (Igs) comprises such a vast number of dif-
ferent molecules to virtually recognise and bind to, through the antibody (Ab) variable region, any non-self struc-
ture, and even self-epitopes, as is the case of auto-Abs. In contrast, the constant region of Abs is mainly involved 
in the effector functions and has less variability. Although several different genes (V and J for light chains, V, D 
and J for heavy chains) encode the variable Ig domains, they are certainly not enough to justify the large number 
of different Igs in nature. Differentiated plasma cells produce diverse Abs through the V(D)J recombination, a 
gene rearrangement process in which the introns are removed, and the various sequences form pairs of different 
light and heavy variable regions1, 2. Moreover, junctional diversity results by addition or subtraction of nucleotides 
during the recombination process between VJ and VDJ genes. Further diversity derives from the somatic hyper-
mutation mechanism, which occurs in the V gene after recombination3.
In previous studies, we have shown that synthetic peptides with sequences identical to Ig fragments related 
to complementarity-determining regions (CDRs) and to constant domains can exert in vitro, ex vivo and/or in 
vivo antimicrobial, antiviral, immunomodulatory and/or anti-tumour activities, regardless of the specificity and 
isotype of the belonging Ab4–8. More recently, a naturally occurring IgM fragment proved to exert antifungal and 
antiviral activity, and also showed a therapeutic effect against an experimental Candida albicans infection9.
These findings led to the speculation that the products of Ig genes could be endowed with innate anti-infective 
activity. Synthetic peptides with the sequence of selected J lambda and J heavy gene products proved to display 
a fungicidal activity in vitro and a therapeutic activity in Galleria mellonella larvae against systemic candidiasis.
These results support the hypothesis that genes encoding peptides ancestrally devoted to innate immunity 
may have been combined in the course of evolution to give rise to antibody molecules, characterised by highly 
specific activity, as effectors of adaptive immunity.
Results
Selection of peptides encoded by immunoglobulin genes. The search for peptides encoded by 
immunoglobulin genes (loci lambda, kappa and heavy) resulted in the selection of four peptides, denominated 
L12P, W12K, G10S and L18R. The amino acid sequences and characteristics of the selected peptides are shown 
in Table 1. The selected peptides were synthesised and evaluated for in vitro fungicidal activity against reference 
yeast strains.
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In vitro biological activity of the selected peptides. Fungicidal activity. The selected peptides 
L12P and L18R exhibited a significant activity against all the investigated yeast strains (representative images in 
Supplementary Fig. S1), with half maximal effective concentration (EC50) values ranging from 0.188 μM (L18R 
against Cryptococcus neoformans 6995) to 0.658 μM (L12P against Malassezia furfur 101) (Table 2). The peptides 
W12K and G10S showed a weaker activity, if any. In preliminary assays performed at the concentration of 100 μg/
ml, their inhibitory activity ranged from 0% to 89% in comparison to the control growth (in the absence of pep-
tides), with the only exception of peptide W12K against C. neoformans 6995 (100% inhibition at 100 μg/ml, EC50 
12.91 μM).
Time-killing curves, determined by incubation over time of C. albicans SC5314 cells with L12P and L18R at 
their minimal fungicidal concentration (5 μg/ml), demonstrated a very rapid candidacidal effect of the peptides. 
In particular, nearly 93% and 95% killing with L12P and nearly 97% and more than 99% killing with L18R was 
observed in 5 and 10 min, respectively (Supplementary Fig. S2).
Haemolytic, cytotoxic, and genotoxic effects. Haemolytic, cytotoxic and genotoxic effects were evaluated on 
human erythrocytes, mammalian cells and peripheral blood mononuclear cells (PBMCs), respectively. The 
selected peptides did not show a significant haemolytic activity, either after 30 or 120 min of incubation. Even at 
the highest tested concentration (500 μM) less than 1% of the erythrocytes lysed with reference to the negative 
control (0% lysis), consisting of erythrocytes suspended in phosphate buffered saline (PBS), in comparison to the 
positive control (erythrocytes suspended in PBS plus Triton 1%, 100% lysis). As the only exception, higher values 
of haemolysis, although always less than 10%, were observed after 120 min in the presence of increasing concen-
trations of L18R (4.4% at 50 μM, 5.8% at 100 μM, 7.5% at 250 μM and 9.6% at 500 μM) (Supplemetary Table S1).
None of the selected peptides was significantly cytotoxic against LLC-MK2 cells, as assessed by a cell viability 
assay using resazurin as indicator. At all concentrations tested, mean values of fluorescence intensity did not 
differ significantly from the ones of the untreated cells, with the exception of L18R at the highest concentrations. 
In the presence of this peptide cell viability was reduced, in comparison to untreated control (100% viability), to 
90.14% and 83.88% at 250 and 500 μM respectively (concentrations several hundred times higher than the EC50) 
(Supplemetary Table S2).
No genotoxic activity was detected in the Comet assay performed on PBMCs with the most active peptides 
(Supplemetary Table S3). Tail DNA values were always very low (<1%) for PBMCs treated with 5 and 10 μM 
L12P and L18R (0.55 ± 0.08, 0.21 ± 0.14, 0.22 ± 0.02 and 0.21 ± 0.06 respectively, in comparison with the negative 
control value of 0.37 ± 0.04 recorded for untreated PBMCs). Accordingly, there were no significant changes in the 
visual score values (109 ± 4.24, 103 ± 1.41, 106 ± 1.00, and 103 ± 1.41, in the presence of 5 and 10 μM L12P and 
L18R respectively, in comparison with 104 ± 2.83 in the absence of peptides).
In vivo toxicity and therapeutic activity of peptides. Toxicity to the host and therapeutic activity 
against C. albicans infection were evaluated for L12P and L18R peptides in G. mellonella larvae. No significant 
difference in survival was detected between larvae inoculated with saline (control group) or with the peptides 
(12.5 mg/kg) showing the lack of toxicity under the adopted experimental conditions. In two independent 
Peptide Locus Gene Amino acid sequence Hydrophobicitya pI M.M. Net charge
L12P Lambda IGLJ1 LCLRNWDQGHRP 0*0+*0-*0++0 8.26 1494.7 2+
W12K Kappa IGKJ1 WTFGQGTKVEIK 0*00*0*+0-0+ 8.59 1393.7 +
G10S Heavy IGHD2-15 GYCSGGSCYS 00**00**0* 5.51 983.2 0
L18R Heavy IGHJ2 LLVLRSLGPWHPGHCLLR 0000+*0000+00+*00+ 10.35 2068.1 4+
Table 1. Characteristics of the selected peptides encoded by immunoglobulin genes. a0: hydrophobic,  
*polar, +, and −: positively charged and negatively charged residues; pI: isoelectric point; M.M.: molecular 
mass (Daltons).
Yeast strain
EC50* (95% confidence intervals) [mol/liter] × 10−6
L12P L18R
Candida albicans SC5314 0.489 (0.445–0.538) 0.443 (0.437–0.549)
C. albicans CA-6 0.556 (0.522–0.591) 0.294 (0.292–0.296)
C. albicans SA40 0.537 (0.531–0.544) 0.315 (0.271–0.366)
C. albicans AIDS68 0.501 (0.468–0.537) 0.449 (0.435–0.463)
C. albicans UM4 0.627 (0.534–0.736) 0.454 (0.414–0.499)
C. glabrata OMNI32 0.546 (0.520–0.574) 0.356 (0.339–0.373)
Cryptococcus neoformans 6995 0.364 (0.353–0.375) 0.188 (0.180–0.196)
Malassezia furfur 101 0.658 (0.574–0.754) 0.527 (0.472–0.586)
Table 2. In vitro fungicidal activity of the selected peptides L12P and L18R. *EC50, half maximal effective 
concentration, calculated by nonlinear regression analysis using Graph Pad Prism 4.01 software.
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experiments, a single administration of both peptides (12.5 mg/kg) led to a significant increase in survival 
of larvae infected with C. albicans cells in comparison to that of control group, i.e. infected larvae inoculated 
with saline. The survival curves of one representative experiment, showing a significant statistical difference 
(p = 0.0001 and p < 0.002 for L12P and L18R, respectively) are depicted in Fig. 1. Median survival time was 108 h 
in L12P-treated group and 36 h in L18R-treated group vs 24 h in saline-injected control group. While 100% of the 
untreated larvae were dead 48 h post-infection, survival was prolonged up to 120 h in the L18R-treated group, 
while 5/16 of the L12P-treated larvae were still alive at day 9.
Induction of apoptosis in C. albicans cells. Phosphatidylserine externalisation and reactivity with 
annexin V was determined by flow cytometry and used to assess whether apoptosis is induced in C. albicans 
SC5314 whole cells after 30 and 60 min treatment with the L12P and L18R peptides at 2 × EC50. Under the 
adopted experimental conditions, the percentage of apoptotic cells on the total gated cells was not significantly 
different in L12P-treated cells in comparison with untreated control cells. Conversely, a significant, although low, 
percentage of apoptotic cells was observed after treatment with L18R peptide (Fig. 2). A CFU assay performed 
on peptide-treated in comparison to control untreated cells confirmed the candidacidal activity of the peptides 
under the adopted experimental conditions.
Peptide-yeast cell interaction. Time-lapse confocal microscopy allowed the investigation of the inter-
action between fluorescein isothiocyanate (FITC)-labeled L12P and L8A peptides and living C. albicans SC5314 
cells. Both peptides entered yeast cells, gathered inside and led to cell death, but in different patterns. As shown in 
Fig. 3, after 5 min the FITC-labeled L12P peptide was found inside most C. albicans cells, except within vacuoles. 
After 15 min, some cells were completely fluorescent and already dead, as shown by propidium iodide internalisa-
tion. Conversely, after 5 min peptide L18R bound to the surface of all yeast cells (Fig. 4, panel A), and progressive 
internalisation and compartmentalisation were observed over time (Fig. 4, panels B,C). A diffuse fluorescence 
was observed only in dead cells (Fig. 4, panels D–F).
Figure 1. In vivo therapeutic activity of L12P and L18R peptides. Groups of 16 Galleria mellonella larvae were 
infected with 5 × 105 cells of Candida albicans SC5314 and administered 1 h later (single injection, 10 μl) with 
peptides (12.5 mg/kg) or saline solution (control group). Larvae were then incubated at 37 °C in the dark for 9 
days, and scored daily for survival.The survival curves of peptide-treated animals were significantly different 
from that of control group, as assessed by the log-rank (Mantel-Cox) test (**p = 0.0016, ***p = 0.0001). Data 
reported are from one representative experiment out of two experiments with comparable results.
Figure 2. Apoptotic effects of the L12P and L18R peptides on Candida albicans SC5314 cells. Phosphatidylserine 
externalisation was analysed by flow cytometry after 30 and 60 min of treatment with peptides at 2 × EC50. 
While no difference was observed between untreated cells (control) and cells treated with L12P, after 
treatment with L18R a significant, although low, percentage of apoptotic cells was observed. Data represent the 
means ± standard deviations from two independent experiments (*p < 0.05 vs control untreated cells).
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Visualisation of the effects of L12P and L18R peptides on C. albicans cells by transmission and 
scanning electron microscopy. As shown in Figs 5 and 6, treatment with L12P and L18R peptides caused 
alterations in the morphology of C. albicans cells in comparison to untreated controls. In transmission elec-
tron microscopy specimens, microbodies were seen in still intact treated cells. Cell surface alterations were also 
observed. Scanning electron microscopy showed masses of cellular debris, apparent cell leakage and deformed 
yeast cells.
Discussion
Over the years, hundreds of peptides with antimicrobial, antiviral and/or immunomodulatory activity have been 
isolated and characterised from diverse vertebrate and invertebrate animals, plants and eukaryotic and prokar-
yotic microorganisms. More than 2,800 of such molecules are currently listed in the Antimicrobial Peptide 
Database (APD3)10. Most antimicrobial peptides, also referred to as host defence peptides, share common fea-
tures, such as small size, net positive charge, an amphipathic structure and affinity for negatively charged phos-
pholipids11–15. In humans, diverse gene-encoded cationic peptides, as α-defensins, cathelicidin LL-37, histatins 
Figure 3. Internalisation of the L12P peptide into Candida albicans SC5314 cells. Confocal images of living 
yeast cells incubated in the presence of the fluorescein-labeled peptide for 5 min and 15 min are presented in 
panels A and C, respectively. The same field is shown by light transmission images in panels B (5 min) and D 
(15 min). L12P entered into most yeast cells within few minutes; empty vacuoles were seen. After 15 min, some 
yeast cells were entirely fluorescent and no longer viable as assessed by propidium iodide internalisation (panel 
E). Panel F: merge of panels C and E. Bar = 10 μm.
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and hepcidin, are produced and play a role in host defense11, 13, 15, 16. Besides these natural molecules recognised to 
be involved in innate immunity, bioactive peptides may derive from the proteolytic cleavage of physiological pro-
teins. Haemoglobin is the source of antimicrobial peptides17, 18, including HB33–61 from the α-chain of bovine 
haemoglobin, active at micromolar concentrations against Gram-positive bacteria and fungi19. Additional exam-
ples are buforins, derived from the protein histone H2A20, the 7–42 fragment from gastric inhibitory polypep-
tide21, lactoferricins from lactoferrin22, fragments of lactalbumin23, and derivatives from the precursor molecule 
pro-opiomelanocortin such as α-melanocyte-stimulating hormone and its carboxy-terminal tripeptide (11–13, 
KPV), able to inhibit Staphylococcus aureus, C. albicans and HIV-1 at picomolar concentrations24, 25. Short pep-
tides derived from CDR H3 sequences proved to maintain the binding properties of the parental Ab and also to 
exert antiviral26, 27 and even anti-tumour activities28.
In our previous works, we demonstrated that synthetic peptides related to CDRs and domains of the constant 
regions of Abs of different classes may display antimicrobial, antiviral, immunomodulatory and/or anti-tumour 
activities, mediated by different mechanisms of action, entirely unrelated to the specificity of the originating Ab4–8.
Figure 4. Internalisation of the L18R peptide into Candida albicans SC5314 cells. Confocal images of living 
yeast cells incubated in the presence of the fluorescein-labeled peptide for 5 min, 30 min, 50 min and 65 min are 
presented in panels A to D. The same field is shown. Labeled L18R bound to the surface of all yeast cells in a few 
minutes, then was progressively internalised by yeast cells. After 65 min, fluorescence was diffused in yeast cells 
that were no longer viable as assessed by propidium iodide internalisation (panel E). Panel F: merge of panels C 
and E. Non-viable yeast cells in the inoculum passively internalised L18R peptide (panel A, arrows). Bar = 10 μm.
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The aim of this work was to evaluate, as a proof of concept, the potential microbicidal activity of synthetic 
peptides (<20 residues), representing the translated products of J and D genes selected from available databases.
The selected peptides showed a direct fungicidal activity, at micromolar concentrations, against several yeast 
species, including Candida strains resistant to conventional antifungal drugs. None of the investigated peptides 
showed haemolytic, cytotoxic or genotoxic activity in vitro against mammalian cells. The absence of in vivo toxic-
ity in the Galleria model was also verified.
L12P and L18R were the most active peptides. Both proved to kill cells of C. albicans in a few minutes. 
Following treatment of C. albicans cells with L18R peptide a significant apoptotic cell death was detected.
The yeast cell penetration mechanism of L12P could likely depend on the cationic R residues that can interact 
with membrane phospholipids in a way Trojan peptides do. Several molecules of L12P would be sufficient to 
cause local disruption of the lipid core. As to peptide L18R, an interaction with the membrane seems plausible 
considering its hydrophobic face. Direct penetration via an energy independent pathway may involve stable or 
transient destabilisation of the membrane, associated with peptide folding on the lipid membrane. Subsequent 
internalisation depends on the peptide concentration, sequence and lipid composition of the membrane.
The main alterations observed by transmission electron microscopy in C. albicans cells treated with L12P and 
L18R (Fig. 5) are the presence of microbodies (peroxisomes) and the retraction of the plasma membrane coupled 
with cell wall alterations. It is conceivable that peptide action on the plasma membrane may generate precur-
sors that have a role in microbodies formation. Microbodies may contain catalase and other enzymes, such as 
flavin-dependent alcohol oxidase and D-amino acid oxidase, and in the case of apoptosis oxidative molecules may 
include ROS, thioredoxin and other species. Membrane retraction and cell wall alterations probably reflect pep-
tide effects on the cytoskeleton, actin filaments and other structures, that may lead to mitochondrial dysfunction.
Observations by scanning electron microscopy (Fig. 6) revealed deformed yeast cells and leakage of cellular 
components. Some cells appeared with a rugged surface suggesting alterations on the cell wall.
The therapeutic activity of L12P and L18R has been demonstrated in an experimental model of systemic 
infection by C. albicans in larvae of G. mellonella, a non-mammalian system which allows a reliable evaluation of 
Figure 5. Transmission electron microscopy of Candida albicans cells treated with L12P and L18R peptides. 
Approximately 107 yeast cells were incubated without (panels A–C, controls) or with the selected peptides 
(125 μg/ml) (panels D–F, cells treated with peptide L12P; panels G–I, cells treated with peptide L18R) for 
60 min. Still intact cells treated with both peptides presented cytoplasmic changes with the presence of a number 
of microbodies (panels D,E,F,I), membrane retraction and cell wall alteration (panels D,F,G,H). Bar: 1000 nm 
(panels A,C,E), 500 nm (panels B,D,F–I).
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in vivo efficacy of in vitro active molecules indipendently from adaptive immunity29. A significant increase in the 
survival of infected larvae was observed after a single peptide injection.
Overall, peptides encoded by Ig genes exerted an effective antifungal activity. Other possible biological func-
tions (antibacterial, antiviral, anti-tumour, immunoregulatory), already recognised for previously described 
Ab-derived peptides4, 5, 7, 8, could be investigated in future studies.
These findings raise the hypothesis that ancestral genes, encoding peptides with nonspecific antimicrobial 
activity, could have been associated, in the course of evolution, to give rise to complex antibody molecules dis-
playing highly specific activities. Such theory, along with the finding, in the human serum, of a peptide undoubt-
edly derived from IgM constant region able to exert diverse anti-infective activities9, may help to establish an 
unsuspected link between innate and adaptive immunity.
Methods
Ethics statement. Blood components were collected from periodical donors of the Transfusion Unit of 
the Azienda Ospedaliera Universitaria di Parma according to the policy of the Italian National Blood Centre 
Guidelines (April 5, 2013). Research did not involve interaction with the donors nor their identification.
Figure 6. Scanning electron microscopy of Candida albicans cells treated with L12P and L18R peptides. 
Approximately 4 × 105 yeast cells were incubated without (panels A and B, controls) or with the selected 
peptides (125 μg/ml) (panels C and D, cells treated with peptide L12P; panels E and F, cells treated with peptide 
L18R) for 60 min. Masses of debris and cell leakage (panels C, E, F), and gross alterations in cell surface (panels 
D and E) were observed after treatment with both peptides. Bar: 1 μm.
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Selection and synthesis of peptides encoded by immunoglobulin genes. The research focused 
on J gene segments (lambda and kappa loci) for the light chain and J and D gene segments (heavy locus) for the 
heavy chain, exploiting the Gene database of the National Center for Biotechnology Information (NCBI, https://
www.ncbi.nlm.nih.gov). Translated products were selected according to different criteria, i.e. presence of posi-
tively charged residues, net charge, isoelectric point, and alternation of hydrophobic/hydrophilic residues in the 
sequence, by using ExPASy Proteomics Tools Compute pI/MW and ProtParam (http://www.expasy.org/proteom-
ics). Selected peptides were synthesised as previously described9 by solid phase peptide synthesis method using a 
multiple peptide synthesiser (SyroII, MultiSynTech GmbH), at CRIBI Biotechnology Center (University of Padua, 
Italy). The purity of peptides, evaluated by analytical reverse phase HPLC, was in the 80–90% range. The peptides 
were solubilised in dimethylsulfoxide at a concentration of 20 mg/ml and subsequently diluted in sterile distilled 
water for experimental use. For all experiments, controls (in the absence of peptides) contained dimethylsulfoxide 
at the proper concentration.
Evaluation of the in vitro fungicidal activity of the selected peptides. The fungicidal activity of 
the selected synthetic peptides was evaluated in vitro by a previously described colony forming unit (CFU) assay 
against five strains of C. albicans (SC5314, CA-6, SA40, AIDS68, and UM4), C. glabrata OMNI32, C. neoformans 
serotype A 6995, and Malassezia furfur 1016. Briefly, approximately 500 viable yeast cells were incubated for 6 h at 
37 °C in the absence (control) or presence of the selected peptides at scalar concentrations. The yeast suspensions 
were then seeded on plates of Sabouraud dextrose agar (SDA) (Candida spp. and C. neoformans), or SDA added 
with 1% Tween 20 (M. furfur), and colonies were enumerated after 48–72 h of incubation at 30 °C. Percent killing 
was calculated with reference to the number of colonies in controls. Each assay was performed in triplicate. The 
EC50 was calculated by nonlinear regression analysis using Graph Pad Prism 4.01 software, San Diego, CA, USA. 
Time kinetics of killing of C. albicans SC5314 was determined, for the most active peptides, by CFU assays after 
incubation of yeast cells for 5, 10, 20, 30, 60, 120, 240, and 360 min with 5 μM peptides.
Evaluation of the haemolytic, cytotoxic, and genotoxic activity of the selected peptides. The 
synthetic selected peptides were evaluated for haemolytic activity against human erythrocytes (blood group 0 
Rh+ ) according to a previously described procedure6. Briefly, 50, 100, 250 e 500 μM peptides in PBS were added 
to erythrocyte suspensions (final erythrocyte concentration, 2.5% v/v). Release of haemoglobin was monitored, 
at 30 and 120 min incubation at 37 °C, by measuring the absorbance at 540 nm of the supernatant obtained after 
centrifugation at 800 g for 10 min. Results were expressed as the percentage of lysed erythrocytes, where controls 
for zero haemolysis (blank) and 100% haemolysis consisted of erythrocytes suspended in PBS and 1% Triton 
X-100, respectively.
Cytotoxicity against mammalian cells was tested exploiting the ability of metabolically active cells to convert 
resazurin to fluorescent resorufin, as previously described9, using the cell line LLC-MK2, already available at 
our laboratory. Briefly, LLC-MK2 monkey kidney epithelial cells cultured on 96-well plates in Eagle’s Minimum 
Essential Medium with 2% fetal bovine serum were treated with 50, 100, 250 e 500 μM peptides for 24 h. Cells 
in medium without peptide served as control. After this period, cells were incubated with resazurin 44 μM in 
serum-free medium for 30 min at 37 °C, then fluorescence intensity was measured at 572 nm. Cell viability was 
expressed as the percent ratio T/C, where T represents the mean value obtained for cells treated with the peptides 
and C the mean value of control.
Genotoxic activity against human PBMCs was evaluated by alkaline Comet assay, as previously described6. 
Briefly, PBMCs cultured in RPMI 1640 medium were treated for 120 min with 5 and 10 μM L12P and L18R at 
37 °C in an atmosphere containing 5% CO2. Cells were exposed at 4 °C overnight to a lysis buffer (2.5 M NaCl, 
10 mM Na2EDTA, 10 mM Tris-HCl, 1% Triton X-100 and 10% dimethylsulfoxide, pH 10), then DNA unwinding 
was achieved over 20 min in an electrophoretic alkaline buffer (1 mM Na2EDTA, 300 mM NaOH, at 0 °C, pH 
>13). The electrophoresis was carried out for 20 min (0.78 V/cm, 300 mA) at 0 °C in the same buffer, followed 
by neutralisation in 0.4 M Tris-HCl, pH 7.5. The slides, stained with 0.75 μl ethidium bromide (10 μg/ml) were 
examined with a fluorescent microscope (Leica DMLS), equipped with a BP 515–560 nm excitation filter and 
an LP 580 nm barrier filter and data were collected using an automatic image analysis system (Comet Assay III, 
Perceptive Instruments Ltd). Fifty randomly-selected cells per slide (two slides per sample) were analysed. DNA 
migration was evaluated by percentage of DNA in comet tail (mean Tail Intensity). A visual score was also calcu-
lated after direct observation by the operator. The length of the comet tail allowed the attribution of the observed 
cells to a class (0 to 4) and the following formula was used: Visual score = number (no.) of class 0 cells + 2 × (no. 
of class 1 cells) + 3 × (no. of class 2 cells) + 4 × (no. of class 3 cells) + 5 × (no. of class 4 cells).
Evaluation of in vivo toxicity and therapeutic activity of selected peptides. In vivo toxicity 
and potential therapeutic efficacy of selected peptides were studied in the G. mellonella model, as previously 
described30. To evaluate peptide toxicity, groups of 16 larvae at their final instar stage (body weight, 400 ± 20 mg) 
were inoculated (10 μl/larva) directly in the haemocoel, via the last left proleg, with the selected peptides (12.5 mg/
kg). Control groups consisted of larvae untouched or inoculated with 10 μl of saline solution. Larvae were then 
transferred to clean Petri dishes (one for each experimental group), incubated at 37 °C in the dark for 9 days, and 
scored daily for survival.
To evaluate potential therapeutic activity of selected peptides, larvae (16/group) were inoculated with 10 μl of 
a C. albicans SC5314 suspension (5 × 105 cells/larva) via the last left proleg. 60 min later, larvae were injected via 
the last right proleg (single injection of 10 μl) with the selected peptides (12.5 mg/kg) or saline (control). Larvae 
injected with saline solution alone served as a further control. Larval survival was monitored daily for up to 9 days 
after infection. Survival curves were compared by the log rank (Mantel-Cox) test using Graph Pad Prism software. 
A p value < 0.05 was considered significant.
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Evaluation of apoptosis profile in C. albicans after treatment with selected peptides. 
Peptide-induced apoptosis in C. albicans SC5314 cells was evaluated by the Muse cell analyzer (Merck Millipore, 
Germany) using the Muse annexin V and dead cell assay kit, as previously described30. Briefly, yeast cells were 
suspended in 100 μl water (5 × 105 cells/ml) in the absence (control) or presence of the selected peptides at a con-
centration equal to 2 × EC50 and incubated for 30 and 60 min at room temperature. Treated and control cell sus-
pensions (90 μl) were added to 10 μl of 10% bovine serum albumin and 100 μl of Muse kit reagent 20 min before 
the measurements, maintaining the mixture in the dark. Data were acquired according to the manufacturer’s 
instructions. The candidacidal activity of the peptides under the adopted conditions was verified by CFU assay.
Confocal microscopy studies. Confocal microscopy studies were performed on living yeast cells according 
to a procedure previously described with minor modifications31. Briefly, 4 × 105 C. albicans SC5314 cells, grown 
overnight at 30 °C with shaking (100 rpm) in yeast extract, peptone, and dextrose broth, were seeded on covers-
lips mounted in a special flow chamber (20 μl). After 30 min, FITC-labeled L12P and L18R peptides were added 
(final concentration 200 μg/ml). Propidium iodide was added (1.5 μM) at predetermined times. The candidacidal 
activity of the peptides, under the adopted conditions, was verified as described above.
Transmission and scanning electron microscopy studies. For transmission electron microscopy 
studies, C. albicans SC5314 germinating cells were obtained by inoculating 1 ml of the yeast broth culture (see 
above) in 10 ml of medium 199, then incubated for 90 min at 37 °C with shaking (150 rpm). Candidal suspensions 
(approximately 107 cells) containing equal numbers of budding and germinating cells were incubated for 60 min 
in the absence (control) or presence of the selected peptides (125 μg/ml) in a final volume of 50 μl. After incuba-
tion, cells were pre-fixed for 5 min with 5% glutaraldehyde in 0.1 M phosphate buffer, pH 6. Pellets obtained after 
centrifugation were packed in solidified 3% agarose. Yeast cells in agarose blocks were fixed for 3 h at room tem-
perature with 2.5% glutaraldehyde in phosphate buffer, then kept overnight at 4 °C. Post-fixation was performed 
with 1% osmium tetroxide for 30 min, followed by dehydration with acetone gradient (25–100%). A prolonged 
infiltration protocol using multiple changes of Durcupan ACM epoxy resin was adopted32, followed by embed-
ding and hardening of the resin for 72 h at 58 °C. Semi-thin sections (0.75 μm) were stained with methylene blue 
and safranin for observation in an optical microscope to confirm the presence of an adequate amount of Candida 
cells. Ultra-thin sections (80 nm) contrasted with 4% uranyl acetate and Reynolds’ lead citrate were examined in 
a Philips EM 208S transmission electron microscope (Fei Europe, Eindhoven, The Netherlands).
For scanning electron microscopy studies, approximately 4 × 105 cells, prepared as above, were incubated 
with the selected peptides (125 μg/ml) for 60 min in a final volume of 20 μl. Slides for microscopic examination 
were prepared as previously described30. Briefly, slides were fixed with a glutaraldehyde-sodium cacodylate buffer, 
washed in sodium cacodylate, then dehydrated by immersion in alcohol solutions in a 25 to 100% gradient. After 
washing in acetone, samples were dried in liquid CO2, fixed on a support and gold coated in an ion-sputtering 
unit. The samples were observed in a Philips 501 scanning electron microscope (15 kV).
The candidacidal activity of the peptides under the adopted conditions was verified as described above.
Data Availability. The data generated or analysed during this study are included in this published article or 
available from the corresponding author.
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